Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1 AND Treatment
15 results:

  • 1. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
    Müller D; Győrffy B
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
    Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
    Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. msept9 Can Monitor the Response and Predict the Prognosis of Stage IV colorectal cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery.
    Liu W; Hu P; Liu J; Chen L
    J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Relationship of DNMT3b expression and sept9 methylation in theprogression of colorectal carcinogenesis].
    He N; Feng G; Dou JH; Tang GB; Qian MR; Chen L; Wu KC
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):925-930. PubMed ID: 33256303
    [No Abstract]    [Full Text] [Related]  

  • 5. Detection of Methylated sept9 in Korean colorectal cancer Patients: Comparison with Previous Studies.
    Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
    Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for colorectal cancer Liver Metastasis.
    Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
    Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Potential of quantitative sept9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DNA methylation based biomarkers in colorectal cancer: A systematic review.
    Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
    Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Detection of colorectal cancer by DNA methylation biomarker sept9: past, present and future.
    Li Y; Song L; Gong Y; He B
    Biomark Med; 2014; 8(5):755-69. PubMed ID: 25123042
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [The new blood test bio-marker sept9 and colorectal carcinoma screening].
    Beneš Z; Sedivcová M; Antoš Z; Kohout P; Puškárová G; Cerník M; Rozmahel M; Shánělová M; Dolina J; Hep A; Trubač M; Stehlík J; Vaněček T; Michal M; Simša J; Kala Z
    Vnitr Lek; 2013 Nov; 59(11):971-6. PubMed ID: 24279440
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Detection of methylated sept9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
    Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
    PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Hypermethylation of the CDH1, sept9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
    Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
    Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Recent patents and advances in genomic biomarker discovery for colorectal cancers.
    Quyun C; Ye Z; Lin SC; Lin B
    Recent Pat DNA Gene Seq; 2010 Jun; 4(2):86-93. PubMed ID: 20426761
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.